Used as a key intermediate in the synthesis of pharmaceuticals, particularly in the development of fluorinated active pharmaceutical ingredients (APIs) where enhanced metabolic stability and bioavailability are required. Its structure supports the creation of compounds with improved binding affinity to biological targets. Commonly employed in the preparation of central nervous system agents and anti-inflammatory drugs. Also utilized in agrochemicals for the production of fluorinated pesticides and herbicides, leveraging the electron-withdrawing properties of fluorine to increase compound stability and activity. Suitable for use in liquid crystal formulations for display technologies due to its polarity and thermal stability.